Correlation Between Innovent Biologics and Arcellx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovent Biologics and Arcellx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovent Biologics and Arcellx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovent Biologics and Arcellx, you can compare the effects of market volatilities on Innovent Biologics and Arcellx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovent Biologics with a short position of Arcellx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovent Biologics and Arcellx.

Diversification Opportunities for Innovent Biologics and Arcellx

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Innovent and Arcellx is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Innovent Biologics and Arcellx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcellx and Innovent Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovent Biologics are associated (or correlated) with Arcellx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcellx has no effect on the direction of Innovent Biologics i.e., Innovent Biologics and Arcellx go up and down completely randomly.

Pair Corralation between Innovent Biologics and Arcellx

Assuming the 90 days horizon Innovent Biologics is expected to under-perform the Arcellx. In addition to that, Innovent Biologics is 1.36 times more volatile than Arcellx. It trades about -0.02 of its total potential returns per unit of risk. Arcellx is currently generating about 0.1 per unit of volatility. If you would invest  8,499  in Arcellx on August 29, 2024 and sell it today you would earn a total of  597.00  from holding Arcellx or generate 7.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Innovent Biologics  vs.  Arcellx

 Performance 
       Timeline  
Innovent Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovent Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Arcellx 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Arcellx are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Arcellx showed solid returns over the last few months and may actually be approaching a breakup point.

Innovent Biologics and Arcellx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovent Biologics and Arcellx

The main advantage of trading using opposite Innovent Biologics and Arcellx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovent Biologics position performs unexpectedly, Arcellx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcellx will offset losses from the drop in Arcellx's long position.
The idea behind Innovent Biologics and Arcellx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges